Page last updated: 2024-09-03

sri 63-675 and 1-palmityl-2-acetylglycerol

sri 63-675 has been researched along with 1-palmityl-2-acetylglycerol in 1 studies

*1-palmityl-2-acetylglycerol: RN given refers to (+-)-isomer; RN for cpd without isomeric designation not available 5/88; platelet activating factor precursor [MeSH]

*1-palmityl-2-acetylglycerol: RN given refers to (+-)-isomer; RN for cpd without isomeric designation not available 5/88; platelet activating factor precursor [MeSH]

Compound Research Comparison

Studies
(sri 63-675)
Trials
(sri 63-675)
Recent Studies (post-2010)
(sri 63-675)
Studies
(1-palmityl-2-acetylglycerol)
Trials
(1-palmityl-2-acetylglycerol)
Recent Studies (post-2010) (1-palmityl-2-acetylglycerol)
21001503

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunham, EW; Ma, YH1

Other Studies

1 other study(ies) available for sri 63-675 and 1-palmityl-2-acetylglycerol

ArticleYear
Antagonism of the vasodilator effects of a platelet activating factor precursor in anesthetized spontaneously hypertensive rats.
    European journal of pharmacology, 1988, Jan-12, Volume: 145, Issue:2

    Topics: Animals; Captopril; Diacylglycerol Cholinephosphotransferase; Glyceryl Ethers; Hemodynamics; Male; Nitroprusside; Phospholipid Ethers; Platelet Activating Factor; Quinolines; Rats; Rats, Inbred SHR; Vasodilator Agents

1988